tradingkey.logo

SI-BONE Inc

SIBN
15.770USD
+0.580+3.82%
Cierre 11/07, 16:00ETCotizaciones retrasadas 15 min
678.33MCap. mercado
PérdidaP/E TTM

Más Datos de SI-BONE Inc Compañía

SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.

Información de SI-BONE Inc

Símbolo de cotizaciónSIBN
Nombre de la empresaSI-BONE Inc
Fecha de salida a bolsaOct 17, 2018
Director ejecutivoMs. Laura A. Francis
Número de empleados349
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 17
Dirección471 El Camino Real, Suite 101
CiudadSANTA CLARA
Bolsa de valoresMoscow Interbank Currency Exchange (MICEX)
PaísUnited States of America
Código postal95050
Teléfono14082070700
Sitio Webhttps://si-bone.com/
Símbolo de cotizaciónSIBN
Fecha de salida a bolsaOct 17, 2018
Director ejecutivoMs. Laura A. Francis

Ejecutivos de SI-BONE Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Independent Director
Independent Director
168.86K
+5.42%
Mr. Jeffrey W. Dunn
Mr. Jeffrey W. Dunn
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
116.31K
-0.25%
Ms. Mika Nishimura
Ms. Mika Nishimura
Independent Director
Independent Director
28.02K
+44.83%
Mr. Anshul Maheshwari
Mr. Anshul Maheshwari
Chief Financial Officer
Chief Financial Officer
22.00K
-13.08%
Ms. Jeryl Hilleman
Ms. Jeryl Hilleman
Independent Director
Independent Director
19.16K
+82.75%
Mr. Thomas A. (Tom) West
Mr. Thomas A. (Tom) West
Independent Director
Independent Director
11.73K
+284.15%
Mr. Daniel W. (Dan) Wolf
Mr. Daniel W. (Dan) Wolf
Independent Director
Independent Director
2.86K
-83.33%
Mr. Michael A. Pisetsky
Mr. Michael A. Pisetsky
Secretary, Chief Business & Legal Affairs Officer
Secretary, Chief Business & Legal Affairs Officer
--
--
Mr. Anthony J. Recupero, Ph.D.
Mr. Anthony J. Recupero, Ph.D.
President - Commercial Operations
President - Commercial Operations
--
--
Ms. Laura A. Francis
Ms. Laura A. Francis
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Independent Director
Independent Director
168.86K
+5.42%
Mr. Jeffrey W. Dunn
Mr. Jeffrey W. Dunn
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
116.31K
-0.25%
Ms. Mika Nishimura
Ms. Mika Nishimura
Independent Director
Independent Director
28.02K
+44.83%
Mr. Anshul Maheshwari
Mr. Anshul Maheshwari
Chief Financial Officer
Chief Financial Officer
22.00K
-13.08%
Ms. Jeryl Hilleman
Ms. Jeryl Hilleman
Independent Director
Independent Director
19.16K
+82.75%
Mr. Thomas A. (Tom) West
Mr. Thomas A. (Tom) West
Independent Director
Independent Director
11.73K
+284.15%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
United States
46.42M
95.47%
International
2.21M
4.53%
Por negocio
Por región
Sin datos

Estadísticas de accionistas

Actualizado: jue., 16 de oct
Actualizado: jue., 16 de oct
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
6.88%
Brown Advisory
6.75%
OrbiMed Advisors, LLC
5.98%
The Vanguard Group, Inc.
5.75%
American Century Investment Management, Inc.
5.37%
Otro
69.26%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
6.88%
Brown Advisory
6.75%
OrbiMed Advisors, LLC
5.98%
The Vanguard Group, Inc.
5.75%
American Century Investment Management, Inc.
5.37%
Otro
69.26%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
42.56%
Investment Advisor/Hedge Fund
33.03%
Hedge Fund
12.03%
Private Equity
5.98%
Individual Investor
2.98%
Research Firm
2.59%
Bank and Trust
0.30%
Pension Fund
0.19%
Family Office
0.09%
Otro
0.25%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
361
41.74M
96.76%
-3.86M
2025Q2
375
42.98M
99.64%
-3.69M
2025Q1
387
43.81M
102.83%
-3.10M
2024Q4
376
42.78M
100.80%
-4.52M
2024Q3
370
42.61M
102.18%
-5.88M
2024Q2
364
42.74M
103.69%
-5.64M
2024Q1
363
42.76M
104.26%
-3.79M
2023Q4
363
41.07M
101.66%
-4.86M
2023Q3
356
41.24M
102.85%
-4.82M
2023Q2
355
40.07M
113.82%
-3.95M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
2.97M
6.88%
-257.35K
-7.98%
Jun 30, 2025
Brown Advisory
2.91M
6.75%
-274.42K
-8.61%
Jun 30, 2025
OrbiMed Advisors, LLC
2.58M
5.98%
-863.87K
-25.09%
Jun 30, 2025
The Vanguard Group, Inc.
2.44M
5.66%
+4.38K
+0.18%
Jun 30, 2025
American Century Investment Management, Inc.
2.32M
5.37%
-325.90K
-12.33%
Jun 30, 2025
Champlain Investment Partners, LLC
2.14M
4.96%
-455.66K
-17.55%
Jun 30, 2025
First Light Asset Management, LLC
1.75M
4.06%
+138.59K
+8.60%
Jun 30, 2025
Silvercrest Asset Management Group LLC
1.48M
3.43%
-142.70K
-8.79%
Jun 30, 2025
Granahan Investment Management, LLC
1.26M
2.93%
-168.37K
-11.75%
Jun 30, 2025
State Street Investment Management (US)
1.03M
2.38%
-53.06K
-4.91%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: jue., 6 de nov
Actualizado: jue., 6 de nov
Nombre
Proporción
SPDR S&P Health Care Equipment ETF
0.79%
Hypatia Women CEO ETF
0.47%
Invesco NASDAQ Future Gen 200 ETF
0.43%
iShares Micro-Cap ETF
0.11%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.11%
iShares U.S. Medical Devices ETF
0.07%
Principal U.S. Small-Cap ETF
0.06%
First Trust Active Factor Small Cap ETF
0.04%
iShares Russell 2000 Growth ETF
0.03%
Vanguard US Momentum Factor ETF
0.03%
Ver más
SPDR S&P Health Care Equipment ETF
Proporción0.79%
Hypatia Women CEO ETF
Proporción0.47%
Invesco NASDAQ Future Gen 200 ETF
Proporción0.43%
iShares Micro-Cap ETF
Proporción0.11%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporción0.11%
iShares U.S. Medical Devices ETF
Proporción0.07%
Principal U.S. Small-Cap ETF
Proporción0.06%
First Trust Active Factor Small Cap ETF
Proporción0.04%
iShares Russell 2000 Growth ETF
Proporción0.03%
Vanguard US Momentum Factor ETF
Proporción0.03%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI